- Establishment of India's first GMP –compliant cell bank repository to support Academic research institutions and Biopharmaceutical Industries Availability of well characterized and affordable cell banks is a major the area in Biopharmaceutical development, such as recombinant therapeutic protein, Biosimilars, vaccines and enzymes etc.
- Affordable, and well characterized cell banks for R&D, QC and production of Biopharmaceuticals include but not limited to, recombinant therapeutic proteins, therapeutic enzymes, and recombinant protein subunit vaccines. Affordability and availability of well characterized cell banks from authentic source are major challenges in Biopharmaceutical development. The availability of a GMP grade cell bank will be an enormous help for Biopharmaceutical development in Nation. This facility will aid to Government of India's 'Make In India' mandate.
- Training of scientists, industry personals and students on GMP guidelines and SOP's related to cell line production and banking. In addition training will be imparted in the area of GMP regulations as per national and international guidelines. The training in the Good Manufacturing Practices (GMP) and regulatory guidelines for a biotherapeutic drugs/ biologics is major thrust area that will be complemented by this facility. The training programme will be well aligned with Indian government's 'Skill India' mandate.
